Recent Finacing
Recent Raise
Neumentum develops non-opioid ketorolac formulations—NTM-001 pre-mixed 24-hour continuous-infusion bag and NTM-002 IV PCA—targeting opioid-level acute and postsurgical analgesia, pursuing Phase III regulatory pathway.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Neumentum.
